These data suggest that RGS3L could additionally protect the heart not only by reducing the Rac1 activity induced by carbachol, but also by interfering with other Rac1-dependent pathways involved in the development of cardiac hypertrophy. Here, RAC1 is linked to cardiac hypertrophy.